[Mishra L, Banker T, Murray J, Byers S, Thenappan A, He AR, et al. Liver stem cells and hepatocellular carcinoma. Hepatology 2009; 49: 318-29.10.1002/hep.22704272672019111019]Search in Google Scholar
[Marquardt JU, Factor VM, Thorgeirsson SS. Epigenetic regulation of cancer stem cells in liver cancer: Current concepts and clinical implications. J Hepatol 2010; 53: 568-77.10.1016/j.jhep.2010.05.003349287720646772]Search in Google Scholar
[Lingala S, Cui YY, Chen X, Ruebner BH, Qian XF, Zern MA, et al. Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. Exp Mol Path 2010; 89: 27-35.10.1016/j.yexmp.2010.05.005290043420511115]Search in Google Scholar
[Park JR, Kim RJ, Lee YK, Kim SR, Roh KJ, Oh SH, et al. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells. J Hepatol 2011; 54: 122-31.10.1016/j.jhep.2010.06.02620952084]Search in Google Scholar
[Ardebili SY, Zajc I, Gole B, Campos B, Herold-Mende C, Drmota S, et al. CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids. Radiol Oncol 2011; 45: 102-15.10.2478/v10019-011-0015-6342373122933943]Search in Google Scholar
[Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, Lau CK, et al. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 2008; 47: 919-28.10.1002/hep.2208218275073]Search in Google Scholar
[Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, et al. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 2008; 13: 153-66.10.1016/j.ccr.2008.01.01318242515]Search in Google Scholar
[Tomuleasa C, Soritau O, Rus-Ciuca D, Pop T, Todea D, Mosteanu O, et al. Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma. J Gastrointestin Liver Dis 2010; 19: 61-7.]Search in Google Scholar
[Kohga K, Tatsumi T, Takehara T, Tsunematsu H, Shimizu S, Yamamoto M, et al. Expression of CD133 confers malignant potential by regulating metallo-proteinases in human hepatocellular carcinoma. J Hepatol 2010; 52: 872-9.10.1016/j.jhep.2009.12.03020395004]Search in Google Scholar
[Ma S, Chan KW, Lee TK, Tang KH, Wo JY, Zheng BJ, et al. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 2008; 6: 1146-53.10.1158/1541-7786.MCR-08-003518644979]Search in Google Scholar
[Na DC, Lee JE, Yoo JE, Oh BK, Choi GH, Park YN. Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study. Exp Mol Pathol 2011; 90: 66-73.10.1016/j.yexmp.2010.10.00320969862]Search in Google Scholar
[Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cel1-1ike properties. Hepatology 2006; 44: 240-51.10.1002/hep.2122716799977]Search in Google Scholar
[Cui F, Wang J, Chen D, Chen YJ. CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer. Oncol Rep 2011; 25: 701-8.]Search in Google Scholar
[Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005; 121: 823-35.10.1016/j.cell.2005.03.03215960971]Search in Google Scholar
[Yin S, Li J, Hu C, Chen X, Yao M, Yan M, et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 2007; 120: 1444-50.10.1002/ijc.2247617205516]Search in Google Scholar
[Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T, Moriwaki H. Characterization of CD133+ hepatocel1u1ar carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 2006; 351: 820-4.10.1016/j.bbrc.2006.10.12817097610]Search in Google Scholar
[Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007; 132: 2542-56.10.1053/j.gastro.2007.04.02517570225]Search in Google Scholar
[Khan MS, Halagowder D, Devaraj SN. Methylated chrysin induces co-ordinated attenuation of the canonical Wnt and NF-kB signaling pathway and upregulates apoptotic gene expression in the early hepatocarcinogenesis rat model. Chem Bio Interact 2011; 193: 12-21.10.1016/j.cbi.2011.04.00721554863]Search in Google Scholar
[Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006; 94: 776-80.10.1038/sj.bjc.6603023236137716495913]Search in Google Scholar
[Hashimoto T, Kikkawa U, Kamada S. Contribution of caspase(s) to the cell cycle regulation at mitotic phase. PLoS One 2011; 6: e18449.10.1371/journal.pone.0018449306816821479177]Search in Google Scholar
[Depraetere V, Golstein P. Dismantling in cell death: molecular mechanisms and relationship to caspase activation. Scand J Immunol 2005; 47: 523-31.10.1046/j.1365-3083.1998.00363.x9652819]Search in Google Scholar
[Vaishnav M, MacFarlane M, Dickens M. Disassembly of the JIP1/JNK molecular scaffold by caspase-3-mediated cleavage of JIP1 during apoptosis. Exp Cell Res 2011; 317: 1028-39.10.1016/j.yexcr.2011.01.011306333921237154]Search in Google Scholar
[Rudner J, Elsaesser SJ, Jendrossek V, Huber SM. Anti-apoptotic Bcl-2 fails to form efficient complexes with pro-apoptotic Bak to protect from Celecoxibinduced apoptosis. Biochemical Pharmacol 2011; 81: 32-42.10.1016/j.bcp.2010.09.00220836993]Search in Google Scholar
[Kim R, Emi M, Matsuura K, Tanabe K. Therapeutic potential of antisense Bcl-2 as a chemosensitizer for patients with gastric carcinoma. Gan To Kagaku Ryoho. 2005; 32: 1540-5.10.1200/jco.2005.23.16_suppl.4050]Search in Google Scholar
[Barrezueta LF, Oshima CT, Lima FO, De Oliveira Costa H, Gomes TS, Neto RA, et al. The intrinsic apoptotic signaling pathway in gastric adenocarcinomas of Brazilian patients: Immunoexpression of the Bcl-2 family (Bcl-2, Bcl-x, Bak, Bax, Bad) determined by tissue microarray analysis. Mol Med Report 2010; 3: 261-7.10.3892/mmr_000000249]Search in Google Scholar
[Chami M, Prandini A, Campanella M, Pinton P, Szabadkai G, Reed JC, et al. Bcl-2 and bax exert opposing effects on Ca2+ signaling, which do not depend on their putative pore-forming region. J Biol Chem 2004; 279: 54581-9.10.1074/jbc.M40966320015485871]Search in Google Scholar
[Samuel MS, Lopez JI, McGhee EJ, Croft DR, Strachan D, Timpson P, et al. Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce epidermal hyperplasia and tumor growth. Cancer Cell 2011; 19: 776-91.10.1016/j.ccr.2011.05.008311554121665151]Search in Google Scholar
[Lee YS, Mollah ML, Sohn KC, Shi G, Kim DH, Kim KH, et al. Ki-Hwan Kim ID3 mediates X-ray-induced apoptosis of keratinocytes through the regulation of β-catenin. J Dermatol Sci 2010; 60: 138-42.10.1016/j.jdermsci.2010.09.00221030215]Search in Google Scholar
[Luo H, Yang Y, Huang F, Li F, Jiang Q, Shi K, et al. Selenite induces apoptosis in colorectal cancer cells via AKT-mediated inhibition of β-catenin survival axis. Cancer Lett 2012; 315: 78-85.10.1016/j.canlet.2011.10.01422074856]Search in Google Scholar
[Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65: 6029-33.10.1158/0008-5472.CAN-05-013716024602]Search in Google Scholar
[Bachour T, Bennett K. The role of microRNAs in breast cancer. J Assoc Genet Technol 2011; 37: 21-8.]Search in Google Scholar
[Lin Z, Flemington EK. miRNAs in the pathogenesis of oncogenic human viruses. Cancer Lett 2011; 305: 186-99.10.1016/j.canlet.2010.08.018302382320943311]Search in Google Scholar
[Kerr TA, Korenblat KM, Davidson NO. MicroRNAs and liver disease. Transl Res 2011; 157: 241-52.10.1016/j.trsl.2011.01.008306395221420035]Search in Google Scholar
[Huang YS, Dai Y, Yu XF, Bao SY, Yin YB, Tang M, et al. Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J Gastroenterol Hepatol 2008; 23: 87-94.10.1111/j.1440-1746.2007.05223.x18171346]Search in Google Scholar
[Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601.10.1038/ncb172218376396]Search in Google Scholar
[Feitelson MA, Lee J. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett 2007; 252: 157-70.10.1016/j.canlet.2006.11.01017188425]Search in Google Scholar